xRead - Olfactory Disorders (September 2023)

20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

667

PATEL et al.

1554. Choi BY, Jeong H, Noh H, Park JY, Cho JH, Kim JK. Effects of olfactory training in patients with postinfectious olfactory dysfunction. Clin Exp Otorhinolaryngol . 2021;14:88–92. 1555. Whitcroft KL, Merkonidis C, Cuevas M, et al. Intranasal sodium citrate solution improves olfaction in post-viral hypos mia. Rhinology . 2016;54:368–374. 1556. Philpott CM, Erskine SE, Clark A, et al. A randomised con trolled trial of sodium citrate spray for non-conductive olfac tory disorders. Clin Otolaryngol . 2017;42:1295–1302. 1557. Whitcroft KL, Ezzat M, Cuevas M, et al. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients. ClinOto laryngol . 2017;42:557–563. 1558. Whitcroft KL, Gunder N, Cuevas M, et al. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients. Eur Arch Otorhinolaryngol . 2021;278:2891–2897. 1559. Panagiotopoulos G, Naxakis S, Papavasiliou A, Filipakis K, Papatheodorou G, Goumas P. Decreasing nasal mucus Ca ++ improves hyposmia. Rhinology . 2005;43:130–134. 1560. Hichami A, Datiche F, Ullah S, et al. Olfactory discrimina tion ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats. Behav Brain Res . 2007;184(1):1–10. 1561. Canhada S, Castro K, Perry IS, Luft VC. Omega-3 fatty acids’ supplementation in Alzheimer’s disease: A systematic review. Nutr Neurosci . 2018;21:529–538. 1562. Lewis EJ, Perkins BA, Lovblom LE, Bazinet RP, Wolever TM, Bril V. Effect of omega-3 supplementation on neuropathy in type 1 diabetes. Neurology . 2017;88:2294–2301. 1563. Gladman SJ, Huang W, Lim SN, et al. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous ω -3 polyunsaturated fatty acids. J Neurosci . 2012;32:563–571. 1564. Yan CH, Rathor A, Krook K, et al. Effect of omega-3 sup plementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection: a multi center prospective randomized controlled trial. Neurosurgery . 2020;87:E91–E98. 1565. Gopinath B, Sue CM, Flood VM, Burlutsky G, Mitchell P. Dietary intakes of fats, fish and nuts and olfactory impairment in older adults. Br JNutr . 2015;114:240–247. 1566. Mazahery H, Conlon CA, Beck KL, et al. A randomised controlled trial of vitamin d and omega-3 long chain polyun saturated fatty acids in the treatment of core symptoms of autism spectrum disorder in children. J Autism Dev Disord . 2019;49:1778–1794. 1567. Quint C, Temmel AF, Hummel T, Ehrenberger K. The quinox aline derivative caroverine in the treatment of sensorineural smell disorders: A proof-of-concept study. Acta Otolaryngol . 2002;122:877–881. 1568. Eby GA, Halcomb WW. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: A double-blind, placebo-controlled clinical trial. Altern Ther HealthMed . 2006;12:34–38. 1569. Hummel T, Heilmann S, Hüttenbriuk KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope . 2002;112:2076– 2080.

biloba, and mometasone nasal spray. Arch Otolaryngol Head NeckSurg . 2009;135:1000–1004. 1537. Heilmann S, Huettenbrink KB, Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. AmJRhinol . 2004;18:29–33. 1538. Yao TC, Huang YW, Chang SM, Tsai SY, Wu AC, Tsai HJ. Association between oral corticosteroid bursts and severe adverse events: a nationwide population-based cohort study. Ann Intern Med . 2020;173:325–330. 1539. Hummel T, Rissom K, Reden J, Hahner A, Weidenbecher M, Huttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope . 2009;119:496–499. 1540. Liu DT, Pellegrino R, Sabha M, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospec tive study including 601 participants. Rhinology . 2020 Sep 9. https://doi.org/10.4193/Rhin20.262. Online ahead of print. 1541. Damm M, Pikart L, Reimann H. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, mul ticenter study. Laryngoscope . 2014;124:826–831. 1542. Lamira JM, Soler ZM, Schlosser RJ. A pilot study of olfac tory training in older hyposmic adults. Am J Rhinol Allergy . 2019;33:650–656. 1543. Pekala K, Chandra RK, Turner JH. Efficacy of olfactory train ing in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol . 2016;6:299–307. 1544. Patel ZM, Wise SK, DelGaudio JM. Randomized controlled trial demonstrating cost-effective method of olfactory training in clinical practice: essential oils at uncontrolled concentra tion. Laryngoscope Investig Otolaryngol . 2017;2:53–56. 1545. Altundag A, Cayonu M, Kayabasoglu G, et al. Modified olfac tory training in patients with postinfectious olfactory loss. Laryngoscope . 2015;125:1763–1766. 1546. Saatci O, Altundag A, Duz OA, Hummel T. Olfactory train ing ball improves adherence and olfactory outcomes in post infectious olfactory dysfunction. Eur Arch Otorhinolaryngol . 2020;277:2125–2132. 1547. Oleszkiewicz A, Hanf S, Whitcroft KL, Haehner A, Hummel T. Examination of olfactory training effectiveness in relation to its complexity and the cause of olfactory loss. Laryngoscope . 2018;128:1518–1522. 1548. Jiang RS, Twu CW, Liang KL. The effect of olfactory training on odor identification in patients with traumatic anosmia. Int Forum Allergy Rhinol . 2019;9:1244–1251. 1549. Poletti SC, Michel E, Hummel T. Olfactory training using heavy and light weight molecule odors. Perception . 2017;46:343–351. 1550. Qiao XF; Bai YH; Wang GP; Li X; Zheng W. Clinical effects of two combinations of olfactory agents on olfactory dysfunction after upper respiratory tract infection during olfactory train ing. Rev Assoc Med Bras (1992) . 2020: 66:18–24. 1551. Fornazieri MA, Garcia EC, Lopes NM, et al. Adherence and efficacy of olfactory training as a treatment for persistent olfac tory loss. Am J Rhinol Allergy . 2020;34:238–248. 1552. Addison AB, Philpott CM. A systematic review of therapeu tic options for non-conductive olfactory dysfunction. Otorhi nolaryngologist . 2018;11:61–71. 1553. Jiang RS, Twu CW, Liang KL. The effect of olfactory training on the odor threshold in patients with traumatic anosmia. Am J Rhinol Allergy . 2017;31:317–322.